Cytosorbents (CTSO) Cash & Current Investments (2010 - 2026)
Cytosorbents' (CTSO) quarterly Cash & Current Investments came in at $4.8 million in Q1 2026, down 63.39% YoY from $13.1 million in Q1 2025, and down 23.19% on a QoQ basis from $6.2 million in Q4 2025.
Cytosorbents (CTSO) Cash & Current Investments (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Cash & Current Investments data on file, last reported at $4.8 million in Q1 2026.
- Quarterly Cash & Current Investments fell 63.39% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (down 63.39% YoY) and the FY2025 annual result came in at $6.2 million, down 57.67% from the prior year.
- Cash & Current Investments declined to $4.8 million in Q1 2026, from $6.2 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $43.0 million in Q1 2022 to a low of $4.8 million in Q1 2026.
- A 5-year average of $14.9 million and a median of $13.1 million in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2025 — Cash & Current Investments soared 52.29% — and 2026, when it tumbled 63.39%.
- Tracing CTSO's Cash & Current Investments over 5 years: stood at $22.1 million in 2022, then slumped by 36.19% to $14.1 million in 2023, then gained by 4.48% to $14.8 million in 2024, then plunged by 57.67% to $6.2 million in 2025, then retreated by 23.19% to $4.8 million in 2026.
- The last three Cash & Current Investments figures came in at $4.8 million (Q1 2026), $6.2 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 4.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.41 Mn |
| Mar 31, 2026 | 4.80 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Jun 30, 2025 | 10.20 Mn |
| Mar 31, 2025 | 13.11 Mn |
| Dec 31, 2024 | 14.76 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 8.46 Mn |
| Mar 31, 2024 | 8.61 Mn |
| Dec 31, 2023 | 14.13 Mn |
| Sep 30, 2023 | 8.36 Mn |
| Jun 30, 2023 | 13.15 Mn |
| Mar 31, 2023 | 19.05 Mn |
| Dec 31, 2022 | 22.14 Mn |
| Sep 30, 2022 | 22.55 Mn |
| Jun 30, 2022 | 30.16 Mn |
| Mar 31, 2022 | 43.02 Mn |
| Dec 31, 2021 | 52.14 Mn |
| Sep 30, 2021 | 61.04 Mn |